West Pharmaceutical price target raised to $365 from $325 at Morgan Stanley
Morgan Stanley raised the firm's price target on West Pharmaceutical to $365 from $325 and keeps an Equal Weight rating on the shares. The firm is updating its model ahead of the earnings report.